2017-07-31 13:22:12 UTC

July 31, 2017

New drugs are in the pipeline. AGA white paper summarizes drug development for this condition.

Treatment of gastroparesis is a major unmet need in the U.S. But the tides are turning — experts feel that the future is brighter than it has ever been. As summarized in a new AGA white paper, Gastroparesis: Clinical and Regulatory Insights for Clinical Trials, published in the August issue of Clinical Gastroenterology and Hepatology (CGH):

  • There is renewed interest from the pharmaceutical and device industry in gastroparesis drug development.
  • FDA has provided helpful guidance to industry.
  • Meaningful endpoints have been developed and validated.
  • There are several promising candidates in the drug development pipeline.

Here is a message for your patients with gastroparesis: there is a renewed focus on finding a treatment for gastroparesis that will alleviate your symptoms and improve your quality of life.

For additional insights into gastroparesis drug development, review the white paper.

The AGA Center for Diagnostics and Therapeutics developed this white paper to provide AGA members with a summary of the discussions that took place during its 2016 Drug Development Conference. You can read more about the process for developing this white paper in an editorial by Colin W. Howden, MD, AGAF, and Nimish B. Vakil, MD, AGAF, in CGH. Also available: white papers on GERD, EoE and functional dyspepsia.

More on Gastroparesis

A Selection of the Best AGA Abstracts of DDW® 2017

July 27, 2017

Read the best AGA abstracts from Digestive Disease Week, published in Gastro.

AGA-Allergan Foundation Pilot Research Award in Gastroparesis

July 10, 2017

This award provides $30,000 for one year to an investigator at any career stage researching the pathophysiology and/or treatment of gastroparesis.

Watch Session Highlights on Neurogastroenterology & Motility at DDW® 2017

July 3, 2017

Whether you missed or want to re-watch the best science and cutting-edge research in neurogastroenterology and GI motility, top session highlights are now available.